申请人:——
公开号:US20030199528A1
公开(公告)日:2003-10-23
The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity. The present inhibitors are novel purine derivatives, attached at position 8 of the purine skeleton to a diamine.
本发明涉及治疗活性和选择性抑制酶DPP-IV的化合物,包括药物组合物和利用这些化合物制造用于治疗与受DPP-IV失活的蛋白质相关的疾病的药物,如2型糖尿病和肥胖症。本发明的抑制剂是新颖的嘌呤衍生物,在嘌呤骨架的位置8处连接到二胺。